Haemonetics Corporation (HAE) Gross profit 2017–2026
Haemonetics Corporation (HAE) annual gross profit history from SEC filings — each fiscal year as reported.
$787.6MFY2026 · since FY2017: $378.5M → $787.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | $787.6M | +5.2% |
| FY2025 | $749.0M | +8.3% |
| FY2024 | $691.5M | +12.4% |
| FY2023 | $615.1M | +21.7% |
| FY2022 | $505.5M | +27.1% |
| FY2021 | $397.8M | -17.9% |
| FY2020 | $484.5M | +16.0% |
| FY2019 | $417.5M | +1.4% |
| FY2018 | $411.9M | +8.8% |
| FY2017 | $378.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice